tirzepatide and osteoporosis Tirzepatide, a dual GLP-1 GIP receptor agonist, promotes bone loss in obese mice via gut microbial-related metabolites Is osteoporosis a contraindication to

It blocks the typical dopamine surge associated with alcohol, reducing the rewarding properties of drinking

Having a supportive partner makes all the difference as you work toward your goals

For someone currently on semaglutide for weight loss and considering a switch, these numbers provide a realistic picture of what to expect

Tirzepatide, a dual GIP and GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management, follows a structured titration schedule with dose increases typically occurring every four weeks

Details on zepbound diarrhea describe how the gut might adjust

The American Diabetes Association (ADA) recommends considering periodic measurement of vitamin B12 levels in patients with type 2 diabetes taking metformin, particularly those with anemia or peripheral neuropathy, though no specific monitoring interval is specified